Sign in
8-K

Current Report

ADC Therapeutics SA Filed Acc 0000950103-25-007282

Material agreement · Exit or restructuring costs · Unregistered share sale

  • Item 1.01 Entry into a material definitive agreement
  • Item 2.05 Costs associated with exit or disposal activities
  • Item 3.02 Unregistered sales of equity securities

From the SEC's structured data for this filing

Loading dp230070_8k.htm…